Selected systematic reviews and meta-analyses of VTE rates in COVID-19 inpatients
| Meta-analysis . | Data cutoff . | Studies included, n . | Patients, n . | Overall VTE prevalence % . | VTE prevalence screened . | VTE not screened . | VTE prevalence ICU, % . | VTE Non-ICU, % . | PE, % . | DVT, % . |
|---|---|---|---|---|---|---|---|---|---|---|
| Chi et al21 | May 2020 | 11 | ∼2 000 | 23.9 | — | — | 30.4 | 13 | 5.6 non-ICU; 15.7 ICU | 13.6 non-ICU; 10.6 ICU |
| Porfidia et al26 | Jun 2020 | 30 | 3 500? | 26 | 13 | 6 | 24 | 9 | 12 | 14 |
| Jiménez et al28 | July 2020 | 49 | >18 000 | 17 | 33.1% | 9.8% | 27.9 | 7.1 | 12.1 | 7.1 |
| Nopp et al20 | August 2020 | 66 | >28 000 | 14.1 | 40.3% | 9.5% | 22.7 | 7.9 | 3.5 non-ICU 13.7 ICU | — |
| Tan et al30 | September 2020 | 102 | 64 000 | 14.7 | 25.2% | 12.4% | 23.2 | 9 | 7.8 | 11.2 |
| Mansory et al29 | December 2020 | 91 | 35 000 | 12.8 | — | — | 24.1 | 7.7 | — | — |
| Meta-analysis . | Data cutoff . | Studies included, n . | Patients, n . | Overall VTE prevalence % . | VTE prevalence screened . | VTE not screened . | VTE prevalence ICU, % . | VTE Non-ICU, % . | PE, % . | DVT, % . |
|---|---|---|---|---|---|---|---|---|---|---|
| Chi et al21 | May 2020 | 11 | ∼2 000 | 23.9 | — | — | 30.4 | 13 | 5.6 non-ICU; 15.7 ICU | 13.6 non-ICU; 10.6 ICU |
| Porfidia et al26 | Jun 2020 | 30 | 3 500? | 26 | 13 | 6 | 24 | 9 | 12 | 14 |
| Jiménez et al28 | July 2020 | 49 | >18 000 | 17 | 33.1% | 9.8% | 27.9 | 7.1 | 12.1 | 7.1 |
| Nopp et al20 | August 2020 | 66 | >28 000 | 14.1 | 40.3% | 9.5% | 22.7 | 7.9 | 3.5 non-ICU 13.7 ICU | — |
| Tan et al30 | September 2020 | 102 | 64 000 | 14.7 | 25.2% | 12.4% | 23.2 | 9 | 7.8 | 11.2 |
| Mansory et al29 | December 2020 | 91 | 35 000 | 12.8 | — | — | 24.1 | 7.7 | — | — |